Cytek Biosciences, Inc. (CTKB) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $201.49M | +0.5% |
| 2024 | $200.45M | +3.9% |
| 2023 | $193.01M | +17.7% |
| 2022 | $164.04M | +28.2% |
| 2021 | $127.95M | +37.8% |
| 2020 | $92.84M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $201.49M | +0.5% |
| 2024 | $200.45M | +3.9% |
| 2023 | $193.01M | +17.7% |
| 2022 | $164.04M | +28.2% |
| 2021 | $127.95M | +37.8% |
| 2020 | $92.84M | — |